¼¼°èÀÇ ÁßÀçÀû ½Å°æ ±â±â ½ÃÀå
Interventional Neurology Devices
»óǰÄÚµå : 1543948
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2024³â 08¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 193 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,301,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,905,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¼¼°èÀÇ ÁßÀçÀû ½Å°æ ±â±â ½ÃÀåÀº 2030³â±îÁö 49¾ï ´Þ·¯¿¡ µµ´Þ

2023³â¿¡ 36¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â ¼¼°èÀÇ ÁßÀçÀû ½Å°æ ±â±â ½ÃÀåÀº 2030³â¿¡´Â 49¾ï ´Þ·¯¿¡ ´ÞÇϸç, ºÐ¼® ±â°£ÀÎ 2023-2030³â CAGRÀº 4.6%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. º» ¸®Æ÷Æ®¿¡¼­ ºÐ¼®ÇÑ ºÎ¹®ÀÇ ÇϳªÀÎ ³ú»öÀü¡¤µ¿¸Æ·ù ÄÚÀϸµ µð¹ÙÀ̽º´Â CAGR 4.8%¸¦ ±â·ÏÇϸç, ºÐ¼® ±â°£ Á¾·á±îÁö 20¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ³ú Ç÷°ü¼ºÇü¼ú & ½ºÅÙÆ® À¯Ä¡ ½Ã½ºÅÛ ºÐ¾ßÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ Áß CAGR 3.1%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº ÃßÁ¤ 9¾ï 7,430¸¸ ´Þ·¯, Áß±¹Àº CAGR 4.3%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ ÁßÀçÀû ½Å°æ ±â±â ½ÃÀåÀº 2023³â¿¡ 9¾ï 7,430¸¸ ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ÀÇ °æÁ¦´ë±¹ÀÎ Áß±¹Àº 2023-2030³â CAGR 4.3%·Î ÃßÀÌÇϸç, 2030³â¿¡´Â 7¾ï 7,360¸¸ ´Þ·¯ÀÇ ½ÃÀå ±Ô¸ð¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ±âŸ ÁÖ¸ñÇØ¾ß ÇÒ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£ Áß CAGRÀº °¢°¢ 4.5%¿Í 3.7%·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 3.8%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°èÀÇ ÁßÀçÀû ½Å°æ ±â±â ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

ÁßÀçÀû ½Å°æ ±â±â¶õ ¹«¾ùÀ̸ç, ¿Ö ½Å°æÇ÷°ü Àå¾Ö Ä¡·á¿¡ ÇʼöÀûÀΰ¡?

ÁßÀçÀû ½Å°æ ±â±â´Â ³úÁ¹Áß, µ¿¸Æ·ù, µ¿Á¤¸Æ ±âÇü(AVM)°ú °°Àº ½Å°æÇ÷°ü ÁúȯÀ» ÃÖ¼Ò Ä§½ÀÀûÀ¸·Î Ä¡·áÇÏ´Â µ¥ »ç¿ëµÇ´Â Ư¼ö ÀÇ·á±â±âÀÔ´Ï´Ù. Ä«Å×ÅÍ, ½ºÅÙÆ®, »öÀü ÄÚÀÏ, Ç÷Àü ȸ¼ö ½Ã½ºÅÛ µî ³úÀÇ º¹ÀâÇÏ°í ¼¶¼¼ÇÑ Ç÷°ü°èÅëÀ» Åë°úÇÒ ¼ö ÀÖµµ·Ï °í¾ÈµÈ ´Ù¾çÇÑ ±â±â°¡ Æ÷ÇԵ˴ϴÙ. ÁßÀçÀû ½Å°æÇÐÀº ȯÀÚ¿¡°Ô ±âÁ¸ °³º¹ ¼ö¼ú¿¡ ºñÇØ ´ú ħ½ÀÀûÀÎ ´ë¾ÈÀ» Á¦°øÇÏ¿© ȸº¹ ½Ã°£À» ´ÜÃàÇϰí, ÇÕº´Áõ À§ÇèÀ» ÁÙÀ̸ç, °á°ú¸¦ °³¼±ÇÒ ¼ö ÀÖÀ¸¸ç, Çö´ë ÀÇÇп¡¼­ ¸Å¿ì Áß¿äÇÑ ºÐ¾ß·Î ÀÚ¸® Àâ¾Ò½À´Ï´Ù. Àü ¼¼°è¿¡¼­ ½Å°æÇ÷°ü ÁúȯÀÇ À¯º´·üÀÌ Áö¼ÓÀûÀ¸·Î Áõ°¡ÇÔ¿¡ µû¶ó ÷´Ü ÁßÀçÀû ½Å°æ Àåºñ¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖÀ¸¸ç, ÀÌ´Â »ý¸íÀ» À§ÇùÇÏ´Â ÁúȯÀ» Ä¡·áÇÏ°í °ü¸®ÇÏ´Â µ¥ ÇʼöÀûÀÎ Åø·Î ÀÚ¸®¸Å±èÇϰí ÀÖ½À´Ï´Ù.

±â¼úÀÇ ¹ßÀüÀº ¾î¶»°Ô ÁßÀçÀû ½Å°æ ±â±â ½ÃÀåÀ» Çü¼ºÇϰí Àִ°¡?

±â¼úÀÇ ¹ßÀüÀº ƯÈ÷ ¿µ»óó¸®, Ä«Å×ÅÍ µðÀÚÀÎ, Àç·á°úÇÐÀÇ Çõ½ÅÀ» ÅëÇØ ÁßÀçÀû ½Å°æ ±â±â ½ÃÀåÀ» Å©°Ô Çü¼ºÇϰí ÀÖ½À´Ï´Ù. °íÇØ»óµµ 3D Ç÷°üÁ¶¿µ¼ú ¹× ½Ç½Ã°£ ¼ö¼ú Áß ¿µ»óÁø´Ü°ú °°Àº ¿µ»óÁø´Ü ±â¼úÀÇ ¹ßÀüÀº ³úÇ÷°ü°è¿¡ ´ëÇÑ »ó¼¼ÇÑ ½Ã°¢È­¸¦ Á¦°øÇÔÀ¸·Î½á ½Å°æÇ÷°ü ½Ã¼úÀÇ Á¤È®¼º°ú ¾ÈÀü¼ºÀ» Çâ»ó½Ã۰í ÀÖ½À´Ï´Ù. º¸´Ù À¯¿¬Çϰí Á¶Á¾ °¡´ÉÇÑ Ä«Å×ÅÍÀÇ °³¹ßÀº ÁßÀç½Ã¼úÀÚÀÇ º¹ÀâÇÑ µ¿¸Æ °æ·Î¸¦ Ž»öÇÏ´Â ´É·ÂÀ» Çâ»ó½ÃÄÑ Ç÷°ü ¼Õ»ó À§ÇèÀ» ÁÙÀÌ°í ½Ã¼ú ¼º°ø·üÀ» Çâ»ó½Ã۰í ÀÖ½À´Ï´Ù. »ýü ÀûÇÕ¼º ¹× ¹æ»ç¼± ºÒÅõ°ú¼º Àç·áÀÇ »ç¿ëÀ» Æ÷ÇÔÇÑ Àç·á °úÇÐÀÇ Çõ½ÅÀº ½ºÅÙÆ® ¹× »öÀü ÄÚÀϰú °°Àº ±â±¸ÀÇ ¾ÈÀü¼º°ú È¿´ÉÀ» Çâ»ó½ÃÄÑ º¹ÀâÇÑ ½Å°æÇ÷°ü ÁúȯÀÇ Ä¡·á¿¡ ´õ¿í È¿°úÀûÀÏ ¼ö ÀÖµµ·Ï Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±â¼ú µ¿ÇâÀº ½Å°æÇ÷°ü Áúȯ ȯÀڵ鿡°Ô º¸´Ù È¿°úÀûÀÌ°í ´ú ħ½ÀÀûÀÎ Ä¡·á ¿É¼ÇÀ» Á¦°øÇϱâ À§ÇØ ÀÇ·á ȯ°æ Àü¹Ý¿¡ °ÉÃÄ ÁßÀçÀû ½Å°æ ±â±âÀÇ Ã¤ÅÃÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

ÀÇ·á ºÐ¾ß¿¡¼­ ÁßÀçÀû ½Å°æ ±â±â¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÏ´Â ÀÌÀ¯´Â ¹«¾ùÀΰ¡?

½Å°æÇ÷°ü ÁúȯÀÇ À¯º´·ü Áõ°¡, Àα¸ °í·ÉÈ­, ÃÖ¼Ò Ä§½À ¼ö¼úÀÇ Ã¤Å÷ü Áõ°¡·Î ÀÎÇØ ÇコÄÉ¾î ºÐ¾ß¿¡¼­ÀÇ ÁßÀçÀû ½Å°æ Àåºñ¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ³úÁ¹ÁßÀº ¿©ÀüÈ÷ Àü ¼¼°è »ç¸Á°ú Àå¾ÖÀÇ ÁÖ¿ä ¿øÀÎÀ¸·Î Ç÷Àü Á¦°Å Àåºñ ¹× »öÀü ÄÚÀϰú °°Àº È¿°úÀûÀÎ Ä¡·á ¿É¼Ç¿¡ ´ëÇÑ Çʿ伺ÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. °í·ÉÈ­´Â µ¿¸Æ·ù, AVM µî ÷´Ü ÁßÀçÀû Ä¡·á°¡ ÇÊ¿äÇÑ ÁúȯÀÇ À§ÇèÀÌ ³ôÀº °í·ÉÈ­µµ ÁßÀçÀû ½Å°æ Àåºñ ¼ö¿ä Áõ°¡¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ȯÀÚ¿Í ÀÇ·áÁøÀº °³º¹ ¼ö¼úÀÇ ´ë¾ÈÀ¸·Î ȸº¹ ½Ã°£ ´ÜÃà, ÀÔ¿ø ±â°£ ´ÜÃà, ÇÕº´Áõ ¹ß»ý·ü °¨¼Ò¸¦ ¿øÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÁßÀçÀû ½Å°æ°ú Àü¹®ÀÇ¿¡ ´ëÇÑ Àü¹® ±³À°ÀÌ °¡´ÉÇØÁ³°í, ³úÁ¹Áß ¼¾ÅͰ¡ È®´ëµÇ¸é¼­ º¹ÀâÇÑ ½Å°æÇ÷°ü ½Ã¼úÀ» ½ÃÇàÇÒ ¼ö ÀÖ´Â ÀÇ·á±â°üÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ÀÌ·¯ÇÑ ÀåºñÀÇ µµÀÔÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ½Å°æÇ÷°ü ÁúȯÀÇ ºÎ´ãÀº °è¼Ó Áõ°¡Çϰí ÀÖÀ¸¸ç, ÁßÀçÀû ½Å°æ Àåºñ¿¡ ´ëÇÑ ¼ö¿ä´Â °è¼Ó Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÁßÀçÀû ½Å°æ°è ±â±â ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÏ´Â ¿äÀÎÀº ¹«¾ùÀΰ¡?

ÁßÀçÀû ½Å°æ ±â±â ½ÃÀåÀÇ ¼ºÀåÀº ±â¼ú ¹ßÀü, Àα¸ µ¿Çâ, ÃÖ¼Òħ½ÀÀû Ä¡·á¿¡ ´ëÇÑ °ü½É Áõ°¡ µî ¿©·¯ °¡Áö ¿äÀο¡ ÀÇÇØ ÃËÁøµÇ°í ÀÖ½À´Ï´Ù. ÁÖ¿ä ÃËÁø¿äÀÎ Áß Çϳª´Â ³úÁ¹Áß ¹× µ¿¸Æ·ù¿Í °°Àº ½Å°æÇ÷°ü ÁúȯÀÇ À¯º´·üÀÌ Áõ°¡Çϰí ÀÖÀ¸¸ç, È¿°úÀûÀÎ Ä¡·á¸¦ À§Çؼ­´Â ÷´Ü ÁßÀçÀû Ä¡·á Àåºñ°¡ ÇÊ¿äÇÏ´Ù´Â Á¡ÀÔ´Ï´Ù. °í·ÉÀÚ´Â ÁßÀçÀû Ä¡·á°¡ ÇÊ¿äÇÑ ½Å°æÇ÷°ü Áúȯ¿¡ °É¸®±â ½±±â ¶§¹®¿¡ ¼¼°è Àα¸ÀÇ °í·ÉÈ­µµ Å« ¼ºÀå ¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. Àúħ½ÀÀû ½Ã¼ú¿¡ ´ëÇÑ ¼±È£µµ°¡ ³ô¾ÆÁö¸é¼­ ½ÃÀåÀ» ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½Ã¼úÀº ±âÁ¸ °³º¹ ¼ö¼ú¿¡ ºñÇØ ºü¸¥ ȸº¹°ú ÇÕº´Áõ À§Çè °¨¼Ò µî ´Ù¾çÇÑ ÀÌÁ¡À» Á¦°øÇϱ⠶§¹®ÀÔ´Ï´Ù. ¿µ»ó ó¸®, Ä«Å×ÅÍ ¼³°è ¹× Àç·áÀÇ ±â¼úÀû ¹ßÀüÀº ÁßÀçÀû ½Å°æÇÐÀû ½Ã¼úÀÇ ¾ÈÀü¼º, À¯È¿¼º ¹× Á¢±Ù¼ºÀ» Çâ»ó½ÃÅ´À¸·Î½á ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÀÇ·á ÀÎÇÁ¶ó¿¡ ´ëÇÑ ÅõÀÚ Áõ°¡¿Í ³úÁ¹Áß Àü¹®¼¾ÅÍÀÇ È®´ë·Î ÀÎÇØ ÁßÀçÀû ½Å°æ°è ±â±â µµÀÔ¿¡ ´ëÇÑ »õ·Î¿î ±âȸ°¡ âÃâµÇ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¿äÀεéÀÌ ÇコÄɾî ȯ°æ¿¡ Áö¼ÓÀûÀ¸·Î ¿µÇâÀ» ¹ÌÄ¡¸é¼­, ½Å°æÇ÷°ü Áúȯ¿¡ ´ëÇÑ È¿°úÀûÀ̰í Áøº¸µÈ Àúħ½ÀÀû Ä¡·á ¿É¼Ç¿¡ ´ëÇÑ ¼ö¿ä·Î ÀÎÇØ ÁßÀçÀû ½Å°æ ±â±â ½ÃÀåÀº Áö¼ÓÀûÀÎ ¼ºÀåÀ» ÀÌ·ê °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

Á¶»ç ´ë»ó ±â¾÷ÀÇ ¿¹(ÃÑ 43°Ç)

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå °³¿ä

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Interventional Neurology Devices Market to Reach US$4.9 Billion by 2030

The global market for Interventional Neurology Devices estimated at US$3.6 Billion in the year 2023, is expected to reach US$4.9 Billion by 2030, growing at a CAGR of 4.6% over the analysis period 2023-2030. Cerebral Embolization & Aneurysm Coiling Device, one of the segments analyzed in the report, is expected to record a 4.8% CAGR and reach US$2.0 Billion by the end of the analysis period. Growth in the Cerebral Angioplasty & Stenting Systems segment is estimated at 3.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$974.3 Million While China is Forecast to Grow at 4.3% CAGR

The Interventional Neurology Devices market in the U.S. is estimated at US$974.3 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$773.6 Million by the year 2030 trailing a CAGR of 4.3% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.5% and 3.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.8% CAGR.

Global Interventional Neurology Devices Market - Key Trends & Drivers Summarized

What Are Interventional Neurology Devices and Why Are They Crucial in Treating Neurovascular Disorders?

Interventional neurology devices are specialized medical instruments used in the minimally invasive treatment of neurovascular disorders, such as strokes, aneurysms, and arteriovenous malformations (AVMs). These devices include catheters, stents, embolization coils, and clot retrieval systems, which are designed to navigate the intricate and delicate vasculature of the brain. Interventional neurology has become a crucial field in modern medicine, as it offers patients less invasive alternatives to traditional open surgeries, leading to faster recovery times, reduced risk of complications, and improved outcomes. As the prevalence of neurovascular disorders continues to rise globally, the demand for advanced interventional neurology devices is increasing, making them essential tools in the treatment and management of these life-threatening conditions.

How Are Technological Advancements Shaping the Interventional Neurology Devices Market?

Technological advancements are significantly shaping the interventional neurology devices market, particularly through innovations in imaging, catheter design, and materials science. Advances in imaging technologies, such as high-resolution 3D angiography and real-time intraoperative imaging, are enhancing the precision and safety of neurovascular procedures by providing detailed visualization of the brain’s vasculature. The development of more flexible and steerable catheters is improving the ability of interventionalists to navigate complex arterial pathways, reducing the risk of vessel injury and improving procedural success rates. Innovations in materials science, including the use of biocompatible and radiopaque materials, are enhancing the safety and efficacy of devices such as stents and embolization coils, making them more effective in treating complex neurovascular conditions. These technological trends are driving the adoption of interventional neurology devices across healthcare settings, as they enable more effective and less invasive treatment options for patients with neurovascular disorders.

Why Is There an Increasing Demand for Interventional Neurology Devices in Healthcare?

The demand for interventional neurology devices is increasing in healthcare due to the growing prevalence of neurovascular disorders, the aging population, and the rising adoption of minimally invasive procedures. Stroke remains a leading cause of death and disability worldwide, driving the need for effective treatment options such as thrombectomy devices and embolization coils. The aging population is also contributing to the demand for interventional neurology devices, as older adults are at higher risk for conditions such as aneurysms and AVMs that require advanced interventional treatment. The trend towards minimally invasive procedures is further fueling demand, as patients and healthcare providers seek alternatives to open surgeries that offer faster recovery times, reduced hospital stays, and lower complication rates. Additionally, the increasing availability of specialized training for interventional neurologists and the expansion of stroke centers are enhancing the adoption of these devices, as more healthcare facilities are equipped to perform complex neurovascular procedures. As the burden of neurovascular diseases continues to grow, the demand for interventional neurology devices is expected to increase.

What Factors Are Driving the Growth in the Interventional Neurology Devices Market?

The growth in the interventional neurology devices market is driven by several factors related to technological advancements, demographic trends, and the increasing focus on minimally invasive treatments. One of the primary drivers is the rising prevalence of neurovascular disorders, such as strokes and aneurysms, which require advanced interventional devices for effective treatment. The aging global population is also a significant growth factor, as older adults are more susceptible to neurovascular conditions that necessitate interventional care. The growing preference for minimally invasive procedures is further propelling the market, as these techniques offer numerous benefits over traditional open surgeries, including faster recovery and reduced risk of complications. Technological advancements in imaging, catheter design, and materials are also driving market growth by improving the safety, efficacy, and accessibility of interventional neurology procedures. Additionally, the increasing investment in healthcare infrastructure and the expansion of specialized stroke centers are creating new opportunities for the adoption of interventional neurology devices. As these factors continue to influence the healthcare landscape, the interventional neurology devices market is expected to experience sustained growth, driven by the need for advanced, effective, and minimally invasive treatment options for neurovascular disorders.

Select Competitors (Total 43 Featured) -

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â